Cirrhosis and Portal Hypertension: Pathologic Aspects

Surgery of the Liver, Biliary Tract and Pancreas: Volumes 1-2, Fourth Edition

Volumn 2, Issue , 2006, Pages 1527-1540

  Wang, H L ^a   Brunt, E M ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859108023     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3256-4.50107-1     Document Type: Chapter

References (110)

1. NH Afdhal and D Nunes (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99 1160-1174.
2. KA Al-Mukhaizeem, et al. (2004) Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 75 225-230.
3. F Alvarez, et al. (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 929-938.
4. P Angulo (2002) Nonalcoholic fatty liver disease. N Engl J Med 346 1221-1231.
5. MJ Arthur (2002) Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 122 1525-1528.
6. G Ayata, et al. (2002) Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 33 1098-1104.
7. BR Bacon (2001) Hemochromatosis: diagnosis and management. Gastroenterology 120 718-725.
8. MA Bailey and EM Brunt (2002) Hepatocellular carcinoma: predisposing conditions and precursor lesions. Gastroenterol Clin North Am 31 641-662.
9. RC Benyon and MJ Arthur (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21 373-384.
10. I Bica, et al. (2000) Hepatic schistosomiasis. Infect Dis Clin North Am 14 583-604.
11. M Blich and Y Edoute (2004) Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol 19 732-737.
12. HL Bonkovsky, et al. (2003) Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol 30 137-144.
13. J Bruix, et al. (2001) Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. J Hepatol 35 421-430.
14. EM Brunt (2000) Liver biopsy interpretation for the gastroenterologist. Curr Gastroenterol Rep 2 27-32.
15. EM Brunt (2000) Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31 241-246.
16. EM Brunt (2002) Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 6 399-420.
17. EM Brunt (2004) Nonalcoholic steatohepatitis. Semin Liver Dis 24 3-20.
18. EM Brunt and DG Tiniakos (2002) Steatosis, steatohepatitis: review of effects on chronic hepatitis C. Curr Hepatitis Rep 1 38-44.
19. EM Brunt, et al. (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 2467-2474.
20. EM Brunt, et al. (2003) Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 16 49-56.
21. SH Caldwell, et al. (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29 664-669.
22. A Canbay, et al. (2004) Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39 273-278.
23. HA Carpenter and AJ Czaja (2002) The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. Clin Liver Dis 6 397-417.
24. RW Carrell and DA Lomas (2002) Alpha 1-antitrypsin deficiency: a model for conformational diseases. N Engl J Med 346 45-53.
25. E Caturelli, et al. (2004) Ultrasound-guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 53 1356-1362.
26. A Chedid (2000) Regression of human cirrhosis. Arch Pathol Lab Med 124 1591.
27. JA Coppell, et al. (2003) Veno-occlusive disease: cytokines, genetics, and haemostasis. Blood Rev 17 63-70.
28. S Cullen and R Chapman (2003) Primary sclerosing cholangitis. Autoimmun Rev 2 305-312.
29. AJ Czaja (1997) Recurrence of nonalcoholic steatohepatitis after liver transplantation. Liver Transpl Surg 3 185-186.
30. LD DeLeve, et al. (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22 27-42.
31. VJ Desmet (1992) What is congenital hepatic fibrosis? Histopathology 20 465-477.
32. VJ Desmet and T Roskams (2003) Reversal of cirrhosis: evidence-based medicine? Gastroenterology 125 629-630.
33. M de Torres and T Poynard (2003) Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2 5-11.
34. RK Dhiman, et al. (2002) Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 17 6-16.
35. HP Dienes, et al. (2002) Autoimmune hepatitis and overlap syndromes. Clin Liver Dis 6 349-362.
36. M Durazzo, et al. (2003) Overlap syndromes of autoimmune hepatitis: what is known so far. Dig Dis Sci 48 423-430.
37. JA Fallowfield and JP Iredale (2004) Reversal of liver fibrosis and cirrhosis—an emerging reality. Scott Med J 49 3-6.
38. P Farci (2003) Delta hepatitis: an update. J Hepatol 39 S212-S219.
39. G Fattovich (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis 23 47-58.
40. P Ferenci (2004) Diagnosis and current therapy of Wilson's disease. Aliment Pharmacol Ther 19 157-165.
41. SL Friedman (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275 2247-2250.
42. D Ganem and AM Prince (2004) Hepatitis B virus infection: natural history and clinical consequences. N Engl J Med 350 1118-1129.
43. DR Gaya, et al. (2003) Hepatic granulomas: a 10 year single centre experience. J Clin Pathol 56 850-853.
44. SA Geller (2000) Coming or going? What is cirrhosis? Arch Pathol Lab Med 124 1587-1588.
45. JD Gitlin (2003) Wilson disease. Gastroenterology 125 1868-1877.
46. M Guido and M Rugge (2004) Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 24 89-97.
47. PS Haber, et al. (2003) Pathogenesis and management of alcoholic hepatitis. J Gastroenterol Hepatol 18 1332-1344.
48. N Havlioglu, et al. (2003) Budd-Chiari syndrome and hepatocellular carcinoma: a case report and review of the literature. Am J Gastroenterol 98 201-204.
49. S Hillaire, et al. (2002) Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 51 275-280.
50. P Hytiroglou (2004) Morphological changes of early human hepatocarcinogenesis. Semin Liver Dis 24 65-75.
51. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22 983-993.
52. JP Iredale, et al. (1998) Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102 538-549.
53. KG Ishak (1998) Sarcoidosis of the liver and bile ducts. Mayo Clin Proc 73 467-472.
54. KG Ishak (2002) Inherited metabolic diseases of the liver. Clin Liver Dis 6 455-479.
55. R Issa, et al. (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126 1795-1808.
56. BM Kamath and DA Piccoli (2003) Heritable disorders of the bile ducts. Gastroenterol Clin North Am 32 857-875.
57. HA Karsan, et al. (2004) Primary prevention of cirrhosis: public health strategies that can make a difference. Postgrad Med 115 25-30.
58. S Kaymakoglu, et al. (1998) Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? J Hepatol 28 78-83.
59. M Kojiro (2004) Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 10 S3-S8.
60. S Kumar, et al. (2003) Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 78 589-598.
61. CL Lai, et al. (2003) Viral hepatitis B. Lancet 362 2089-2094.
62. MM Lai (2002) Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 122 568-571.
63. IA LeClercq, et al. (2002) Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37 206-213.
64. U Leuschner (2003) Primary biliary cirrhosis: presentation and diagnosis. Clin Liver Dis 7 741-758.
65. JK Limdi and JR Crampton (2004) Hereditary haemochromatosis. QJM 97 315-324.
66. A Lonardo, et al. (2004) Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 126 586-597.
67. G Marchesini, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 1844-1850.
68. GW McCaughan and J George (2004) Fibrosis progression in chronic hepatitis C virus infection. Gut 53 318-321.
69. IG McFarlane (2002) Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 6 317-333.
70. IG McFarlane (2002) Definition and classification of autoimmune hepatitis. Semin Liver Dis 22 317-324.
71. FD Mendes and KD Lindor (2004) Primary sclerosing cholangitis. Clin Liver Dis 8 195-211.
72. KV Menon, et al. (2001) Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc 76 1021-1029.
73. KV Menon, et al. (2004) The Budd-Chiari syndrome. N Engl J Med 350 578-585.
74. J Misdraji, et al. (2004) Autoimmune hepatitis with centrilobular necrosis. Am J Surg Pathol 28 471-478.
75. E Molina and KR Reddy (2001) Noncirrhotic portal hypertension. Clin Liver Dis 5 769-787.
76. Y Nakanuma, et al. (2001) Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 197 65-76.
77. PG O'Connor and RS Schottenfeld (1998) Patients with alcohol problems. N Engl J Med 338 592-602.
78. K Okuda (2002) Non-cirrhotic portal hypertension versus idiopathic portal hypertension. J Gastroenterol Hepatol 17 S204-S213.
79. M Okudaira, et al. (2002) Idiopathic portal hypertension and its pathology. Semin Liver Dis 22 59-72.
80. J Ong, et al. (2001) Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 7 797-801.
81. DH Perlmutter (2000) Liver injury in alpha 1-antitrypsin deficiency. Clin Liver Dis 4 387-408.
82. A Pietrangelo (2004) Hereditary hemochromatosis: a new look at an old disease. N Engl J Med 350 2383-2397.
83. M Pinzani and F Marra (2001) Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 21 397-416.
84. S Pol, et al. (2004) Reversibility of hepatitis C virus-related cirrhosis. Hum Pathol 35 107-112.
85. A Poonawala, et al. (2000) Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32 689-692.
86. T Poynard, et al. (2002) Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122 1303-1313.
87. T Poynard, et al. (2003) Viral hepatitis C. Lancet 362 2095-2100.
88. G Ramadori and B Saile (2004) Portal tract fibrogenesis in the liver. Lab Invest 84 153-159.
89. F Ramalho (2003) Hepatitis C virus infection and liver steatosis. Antiviral Res 60 125-127.
90. MB Ray (2000) Regression of cirrhosis: a timely topic. Arch Pathol Lab Med 124 1589-1590.
91. HJ Rodriguez and NM Bass (2003) Primary sclerosing cholangitis. Semin Gastrointest Dis 14 189-198.
92. M Roncalli (2004) Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy: a Western experience. Liver Transpl 10 S9-S15.
93. TA Roskams, et al. (2003) Histopathology of portal hypertension: a practical guideline. Histopathology 42 2-13.
94. TA Roskams, et al. (2004) Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39 1739-1745.
95. L Rubbia-Brandt, et al. (2004) Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 53 406-412.
96. H Sakugawa, et al. (2003) Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan. Hepatogastroenterology 50 2005-2008.
97. WB Salt II (2004) Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. J Insur Med 36 27-41.
98. A Sanjeevi, et al. (2003) Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients. Transplant Proc 35 2977-2980.
99. SK Sarin and D Kapoor (2002) Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 17 526-534.
100. C Selmi, et al. (2004) Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol 38 264-271.
101. C Stedman (2002) Herbal hepatotoxicity. Semin Liver Dis 22 195-206.
102. A Suriawinata and R Xu (2004) An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis 24 77-88.
103. K te Sligte, et al. (2004) Nonalcoholic steatohepatitis: review of a growing medical problem. Eur J Intern Med 15 10-21.
104. S Tome and MR Lucey (2004) Current management of alcoholic liver disease. Aliment Pharmacol Ther 19 707-714.
105. DC Valla and JP Benhamou (2000) Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis 4 269-285.
106. D Vergani and G Mieli-Vergani (2003) Autoimmune hepatitis. Autoimmun Rev 2 241-247.
107. JM Vierling (2004) Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis 8 177-194.
108. M Wadleigh, et al. (2003) Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol 10 451-462.
109. IR Wanless, et al. (2000) Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 124 1599-1607.
110. ES Zafrani (2004) Nonalcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch 444 3-12.